DaVita News

Barclays Keeps Their Hold Rating on DaVita (DVA)

TipRanksApr 15 04:26 ET

Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and DaVita (DVA)

TipRanksApr 3 04:01 ET

Deutsche Bank Adjusts DaVita Price Target to $135 From $120, Maintains Hold Rating

MT NewswiresMar 8 10:48 ET

DaVita Analyst Ratings

BenzingaMar 6 16:05 ET

TD Cowen Sticks to Their Hold Rating for DaVita (DVA)

TipRanksFeb 25 20:55 ET

DaVita Analyst Ratings

BenzingaFeb 20 09:16 ET

DaVita Analyst Ratings

BenzingaFeb 15 11:53 ET

UBS Adjusts DaVita Price Target to $145 From $134, Maintains Buy Rating

MT NewswiresFeb 15 11:29 ET

DaVita Analyst Ratings

BenzingaFeb 14 14:50 ET

UBS Adjusts DaVita Price Target to $134 From $113, Maintains Buy Rating

MT NewswiresFeb 14 12:29 ET

DaVita Analyst Ratings

BenzingaFeb 14 08:13 ET

Maintaining a Sell Rating on DaVita Amid Long-Term Growth Concerns and Cost Management Challenges

TipRanksFeb 14 05:45 ET

UBS Maintains Buy on DaVita, Lowers Price Target to $113

BenzingaNov 17, 2023 10:58 ET

DaVita Analyst Ratings

BenzingaNov 17, 2023 10:56 ET

Deutsche Bank Adjusts DaVita Price Target to $90 From $113, Maintains Hold Rating

MT NewswiresNov 8, 2023 10:43 ET

DaVita's Strong Quarter Overshadowed by Volume Normalization and Pricing Concerns: A Sell Rating Reiteration

TipRanksNov 8, 2023 05:57 ET

Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), DaVita (DVA) and Demant (OtherWILLF)

TipRanksNov 8, 2023 03:40 ET

Hold Rating on DaVita's Stock: An Analysis of 3Q23 Results, Raised 2023 Guidance, and Anticipated Share Repurchase Program

TipRanksNov 7, 2023 21:45 ET

Truist Securities Maintains Hold on DaVita, Lowers Price Target to $104

BenzingaOct 11, 2023 15:58 ET

DaVita Analyst Ratings

BenzingaOct 11, 2023 15:57 ET